Evolus, Inc. Insider Trading for January 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Evolus, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Evolus, Inc. for January 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 24 2020 | EOLS | Evolus, Inc. | Jafar Michael M. | Chief Marketing Off ... | Option Exercise | A | 10.19 | 45,000 | 458,550 | 45,000 | |
| Jan 24 2020 | EOLS | Evolus, Inc. | Jafar Michael M. | Chief Marketing Off ... | Grant | A | 0.00 | 26,000 | 0 | 89,000 | 63 K to 89 K (+41.27 %) |
| Jan 24 2020 | EOLS | Evolus, Inc. | Avelar Rui | See Remarks | Option Exercise | A | 10.19 | 45,000 | 458,550 | 45,000 | |
| Jan 24 2020 | EOLS | Evolus, Inc. | Avelar Rui | See Remarks | Grant | A | 0.00 | 26,000 | 0 | 96,802 | 70.8 K to 96.8 K (+36.72 %) |
| Jan 24 2020 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Option Exercise | A | 10.19 | 45,000 | 458,550 | 45,000 | |
| Jan 24 2020 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Grant | A | 0.00 | 26,000 | 0 | 53,388 | 27.4 K to 53.4 K (+94.93 %) |
| Jan 24 2020 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks | Option Exercise | A | 10.19 | 141,910 | 1,446,063 | 141,910 | |
| Jan 24 2020 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks | Grant | A | 0.00 | 82,070 | 0 | 82,070 | 0 to 82.1 K |
| Jan 24 2020 | EOLS | Evolus, Inc. | BLANK SIMONE | Director | Option Exercise | A | 10.19 | 23,458 | 239,037 | 23,458 | |
| Jan 24 2020 | EOLS | Evolus, Inc. | Hau Bosun | Director | Option Exercise | A | 10.19 | 23,458 | 239,037 | 23,458 | |
| Jan 24 2020 | EOLS | Evolus, Inc. | Romine Kristine | Director | Option Exercise | A | 10.19 | 23,458 | 239,037 | 23,458 | |
| Jan 24 2020 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Option Exercise | A | 10.19 | 23,458 | 239,037 | 23,458 | |
| Jan 24 2020 | EOLS | Evolus, Inc. | HAYMAN ROBERT | Director | Option Exercise | A | 10.19 | 23,458 | 239,037 | 23,458 | |
| Jan 24 2020 | EOLS | Evolus, Inc. | Malik Vikram | Director | Option Exercise | A | 10.19 | 23,458 | 239,037 | 23,458 | |
| Jan 24 2020 | EOLS | Evolus, Inc. | FARRELL PETER C | Director | Option Exercise | A | 10.19 | 23,458 | 239,037 | 23,458 | |
| Jan 24 2020 | EOLS | Evolus, Inc. | Parschauer Karah Herdman | Director | Option Exercise | A | 10.19 | 23,458 | 239,037 | 23,458 | |
| Jan 10 2020 | EOLS | Evolus, Inc. | AEON Biopharma, Inc. | Sell | J | 0.00 | 8,662,346 | 0 | 0 | 8.7 M to 0 (-100.00 %) | |
| Jan 08 2020 | EOLS | Evolus, Inc. | Avelar Rui | See Remarks | Sell | S | 10.71 | 39,442 | 422,282 | 70,802 | 110.2 K to 70.8 K (-35.78 %) |